| Literature DB >> 11218915 |
Abstract
Given the poor prognosis of HCC and the therapeutic challenge posed by underlying liver cirrhosis, efforts and resources must be directed towards preventive strategies. Return on the investment in such research is likely to be greater than can be expected from treatment of advanced disease.Entities:
Mesh：
Substances：
Year: 2001 PMID： 11218915 DOI： 10.1016/s1089-3261(05)70160-4
Source DB: PubMed Journal: Clin Liver Dis ISSN： 1089-3261 Impact factor: 6.126